日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proprietary alpha-amylase inhibitor formulation from white kidney bean (Phaseolus vulgaris L.) promotes weight and fat loss: a 12-week, double-blind, placebo-controlled, randomized trial

一项为期 12 周的双盲、安慰剂对照、随机试验表明,源自白芸豆(Phaseolus vulgaris L.)的专有 α-淀粉酶抑制剂配方可促进体重和脂肪减少。

Jäger, Ralf; Abou Sawan, Sidney; Purpura, Martin; Grube, Barbara; Röske, Yvette; De Costa, Patricia; Chong, Pee-Win

Flaxseed Mucilage (IQP-LU-104) Reduces Body Weight in Overweight and Moderately Obese Individuals in a 12-week, Three-Arm, Double-Blind, Randomized, and Placebo-Controlled Clinical Study

一项为期 12 周、三组、双盲、随机、安慰剂对照的临床研究表明,亚麻籽粘液 (IQP-LU-104) 可降低超重和中度肥胖个体的体重。

Bongartz, Udo; Hochmann, Uwe; Grube, Barbara; Uebelhack, Ralf; Alt, Felix; Erlenbeck, Constantin; Peng, Li Vern; Chong, Pee Win; De Costa, Patricia

Investigation of the natural supplement IQP-AS-119 for the prevention of upper respiratory tract infections in marathon race participants: A randomized, double-blind, placebo-controlled pilot study

天然补充剂 IQP-AS-119 预防马拉松参赛者上呼吸道感染的研究:一项随机、双盲、安慰剂对照的初步研究

Bongartz, Udo; Hochmann, Uwe; Pohl, Ute; Bothe, Gordana; Costa, Patricia De; Chong, Pee-Win; Chew, Lynette; Uebelhack, Ralf

Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects

一项双盲、随机、三臂、安慰剂对照的临床研究,旨在评估两种剂量的 IQP-AE-103 在降低超重和中度肥胖受试者体重方面的益处和耐受性。

Uebelhack, Ralf; Bongartz, Udo; Seibt, Stephanie; Bothe, Gordana; Chong, Pee Win; De Costa, Patricia; Wszelaki, Natalia

Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects"

更正:一项双盲、随机、三臂、安慰剂对照的临床研究,旨在评估两种剂量的 IQP-AE-103 在降低超重和中度肥胖受试者体重方面的益处和耐受性

Uebelhack, Ralf; Bongartz, Udo; Seibt, Stephanie; Bothe, Gordana; Chong, Pee Win; De Costa, Patricia; Wszelaki, Natalia

Sleep Promoting Effects of IQP-AO-101: A Double-Blind, Randomized, Placebo-Controlled Exploratory Trial

IQP-AO-101促进睡眠的作用:一项双盲、随机、安慰剂对照的探索性试验

Bongartz, Udo; Tan, Bee-Kwan; Seibt, Stephanie; Bothe, Gordana; Uebelhack, Ralf; Chong, Pee-Win; Wszelaki, Natalia

Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial

评估 IQP-CL-101(黄酮类药物)在改善肠易激综合征症状方面的疗效和耐受性:一项双盲、随机、安慰剂对照临床试验

Alt, Felix; Chong, Pee-Win; Teng, Emily; Uebelhack, Ralf

Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study

Litramine (IQP-G-002AS) 维持体重:一项为期 24 周的双盲、随机、安慰剂对照研究

Grube, Barbara; Chong, Pee-Win; Alt, Felix; Uebelhack, Ralf

IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study

IQP-GC-101 可降低体重和体脂含量:一项随机、双盲、安慰剂对照研究

Chong, Pee-Win; Beah, Zhi-Ming; Grube, Barbara; Riede, Linda

Safety and efficacy of Nasya/Prevalin in reducing symptoms of allergic rhinitis

Nasya/Prevalin 在缓解过敏性鼻炎症状方面的安全性和有效性

Stoelzel, Katharina; Bothe, Gordana; Chong, Pee Win; Lenarz, Minoo